NEWS & AWARDS
ALL SYNAPSY'S NEWS
SEARCH SYNAPSY’S NEWS
JUMP TO A SPECIFIC MONTH
Protecting the intellectual abilities of people at risk for psychosis
1 June 2021
A Synapsy team based at UNIGE has found that a class of drugs can protect the development of intellectual abilities in people at risk of psychosis, if prescribed before adolescence....
Read More
Lactate reveals all about its antidepressant prowess
27 May 2021
Neuroscientists at Synapsy have identified one of the mechanisms behind the antidepressant effect of lactate, a molecule produced by the body during exercise. Its key features – lactate, NADH and...
Read More
8 Replies
Overcoming long-term trauma can be facilitated
21 May 2021
Older traumatic experiences are harder to get over compared to recent ones, and Synapsy scientists based at EPFL have started to understand why – at the level of brain circuits...
Read More
Is schizophrenia the cost of a poor brain optimisation?
23 March 2021
Patients with 22q11.2 deletion syndrome have a high risk of developing schizophrenia. According to a recent study by neuroscientists from Synapsy, the Swiss National Research Centre of Competences in Research...
Read More
Why making the right choice is difficult when you’re stressed
9 March 2021
Study by members of Synapsy, the Swiss National Centre of Competence in Research in psychiatric disorders, explains why we make poor decisions after stress even when motivated by the prospect...
Read More
Invitation for entries for the Research prize of the Swiss Brain League
9 March 2021
Every two years, the Swiss Brain League awards a prize of CHF 20,000 to a Swiss research group in recognition of its outstanding scientific contribution in the field of neurological...
Read More
Has the ideal target for treating anxiety been discovered?
11 February 2021
Synapsy’s neuroscientists based at EPFL have identified a cell molecule that can regulate anxiety and prevent depression. Located at the crossroads of multiple cellular mechanisms, this molecule reconciles the great...
Read More
Poor wiring in the centre of the brain leads to psychosis
9 February 2021
Psychosis is linked to abnormalities in brain development. A team from the Synapsy National Centre of Competences in Research has demonstrated that the regions of the brain involved in processing...
Read More
Best wishes for 2021
24 December 2020
The Management Team wishes You all the Best for the New Year!
Read More
From academia to entrepreneurship – seizing an opportunity to make a significant contribution to the treatment of neurological disorders
17 December 2020
We spoke with Charles Finsterwald, PhD, Chief Scientific Officer and co-founder of the start-up Gliapharm about his career path and his decision to switch from fundamental research to application.An interest...
Read More
Lactate, a prospect for the treatment of depression
17 December 2020
According to WHO, more than 264 million people in the world suffer from depression, a disorder that has a major impact on all facets of the lives of those it...
Read More
Holography and cellular reprogramming in the quest for biomarkers
17 December 2020
Bipolar disorders affect some 2% of the population. Patients present a wide variety of clinical symptoms of which many can be especially handicapping. A new approach to find biomarkers, driven...
Read More
A career at the intersection of physics and psychiatry
17 December 2020
Pierre Marquet’s career path has been rather untypical. Combining qualifications in physics and psychiatry-psychotherapy, he is a clinical researcher “par excellence”, engaged for over 20 years in the development of...
Read More
From science to yoga — and back to science
17 December 2020
After initial studies in science, Zeynep Knight-Celen opts for a life practicing and teaching yoga. Ten years later her interest in the workings of the mind rekindles her scientific curiosity...
Read More
A psychologist in a clinical research team
17 December 2020
Ryan Murray’s work within Synapsy WP#5 focuses on measuring brain reactivity to and recovery from psychosocial stress within clinical patients and healthy controls. He talked to us about his role...
Read More
Genetics to stratify the WP#5 cohort
17 December 2020
Giorgio Pistis is profiling polygenic scores to understand whether genetic risks associated with particular pathophysiological pathways are higher in specific sub-groups of patients of the mood disorder cohort. Synapsy met...
Read More
Editorial – by Camilla Bellone
17 December 2020
2020 has been a challenging year for the Synapsy community and for the whole society. The impact of the COVID-19 pandemic on health, economy and employment has been unprecedented worldwide....
Read More
Zoom Conference on Equal opportunity with Prof. Dr. Tom Welton
8 October 2020
A open conference organized by NCCR Molecular Systems with Prof. Dr. Tom Welton on the topic "Scientific Excellence and Equality – a Contradiction?" will take place November 4th, 13:30-15:10 on...
Read More
Johannes Gräff promoted to associate professor
1 October 2020
Prof. Johannes Gräff, Synapsy principal investigator, has been promoted to Associate Professor of Life Sciences at the School of Life Sciences at EPFL. At its meeting of 23/24 September 2020...
Read More
Obsessive Compulsive Disorders: How to treat OCD?
7 September 2020
The fourth most common psychiatric illness, OCD affects between 2 and 3% of the population. Obsessive compulsive disorder, called OCD, is a psychological disorder. It is characterized by distressing obsessions...
Read More
